J
688426
vs
S
Shanghai Composite
Over the past 12 months, Jiangsu Cowin Biotech Co Ltd has underperformed Shanghai Composite, delivering a return of -1% compared to the Shanghai Composite's +22% growth.
Stocks Performance
688426 vs Shanghai Composite
Performance Gap
688426 vs Shanghai Composite
Performance By Year
688426 vs Shanghai Composite
Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.
Jiangsu Cowin Biotech Co Ltd
Glance View
Jiangsu Cowin Biotech Co., Ltd. engages in the provision of molecular testing services as well as the research and development of molecular testing products. The company is headquartered in Taizhou, Jiangsu and currently employs 603 full-time employees. The company went IPO on 2022-10-25. The firm is also in the business of molecular testing services. Molecular detection products include molecular detection raw materials enzymes, nucleic acid preservation reagents, nucleic acid extraction and purification reagents and molecular diagnostic kits. The firm's products are exported to the United States, Peru, Germany and other countries and regions.
